Adipose–Muscle Crosstalk in COPD Cachexia: Early Adipose Atrophy Drives Subsequent Muscle Wasting
Journal of Cachexia, Sarcopenia and Muscle · 2025-12 · 16 (6)
DOI: 10.1002/jcsm.70154 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, online erschienen am 09.12.2025. Verfasst von Takashi Shimada und 18 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Muscular Atrophy, Cachexia, Adipose Tissue. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: COPD
Abstract (Originalsprache)
Background
Chronic obstructive pulmonary disease (COPD) is frequently associated with cachexia, leading to poor prognoses and reduced quality of life. However, the mechanisms underlying adipose tissue atrophy, its pathological significance and its interaction with skeletal muscle remain poorly understood. We hypothesised that adipose tissue atrophy precedes muscle wasting in COPD‐associated cachexia, and muscle atrophy progresses through adipose–muscle crosstalk.
Methods
We analysed chest computed tomography scans of 185 patients with COPD to quantify the cross‐sectional areas of the pectoralis muscle (PM), subcutaneous adipose tissue (SAT) and epicardial adipose tissue (EAT), and the percentage of low attenuation area (LAA%) as an index of emphysema. To elucidate the pathophysiological mechanisms underlying cachexia in COPD, we performed histological and molecular analyses of the lung, muscle and adipose tissues over time in a cigarette smoke–induced emphysema mouse model. Further, we used an in vitro culture system of differentiated adipocytes (3T3‐L1) and myotubes (C2C12) to study the effects of cigarette smoke extract (CSE) on adipose–muscle interaction.
Results
In patients with COPD, the areas of PM, SAT and EAT all demonstrated significant negative correlations with LAA%; notably, PM and EAT were independently associated with the extent of emphysematous changes. In the smoke‐exposed murine model, adipose tissue atrophy was observed after 1 month of exposure, accompanied by increased expressions of IL‐6 and IL‐1β, macrophage infiltration and the upregulation of the lipolytic enzymes ATGL and HSL. The adipose atrophy had further progressed after 3 months of exposure, and the high expression of UCP1 was sustained, which suggested the browning of adipose tissue. Conversely, muscle atrophy was not evident at 1 month but became apparent after 3 months, coinciding with emphysema development. This was associated with the downregulation of the myogenic markers MyoD and Myogenin and the upregulation of the muscle degradation marker Atrogin‐1. In vitro experiments revealed that CSE exposure reduced lipid droplet content and induced IL‐6 and IL‐1β expressions in adipocytes. Conditioned media from CSE‐treated adipocytes triggered myotube atrophy and downregulated MyoD and Myogenin but upregulated Atrogin‐1.
Conclusions
Our findings indicate that cigarette smoke‐induced adipose tissue atrophy precedes muscle wasting, and alterations in adipose tissue may contribute to muscle atrophy progression. Adipose tissue dysfunction may be implicated in the development of cachexia in patients with COPD, highlighting its potential as a therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
- Department of Respiratory Medicine, Japan Community Health Care Organization (JCHO) Saitama Medical Center, Saitama, Japan.
- Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
- Department of Radiology, Keio University School of Medicine, Tokyo, Japan.
- Department of Respiratory Medicine, Saitama Medical University, Saitama, Japan.
- Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Kanagawa, Japan.
ORCID-Profile: Shotaro Chubachi
Zitieren
APA
Shimada, T., Chubachi, S., Nishikawa, K., Arai, T., Iizuka, H., Otake, S., Sakurai, K., Hamamoto, J., Sasaki, M., Maetani, T., Tanabe, N., Masaki, K., Kabata, H., Miyata, J., Yamada, Y., Jinzaki, M., Nakamura, H., Asano, K., & Fukunaga, K. (2025). Adipose–Muscle Crosstalk in COPD Cachexia: Early Adipose Atrophy Drives Subsequent Muscle Wasting. Journal of Cachexia, Sarcopenia and Muscle, 16(6). https://doi.org/10.1002/jcsm.70154
Vancouver
Shimada T, Chubachi S, Nishikawa K, Arai T, Iizuka H, Otake S, et al. Adipose–Muscle Crosstalk in COPD Cachexia: Early Adipose Atrophy Drives Subsequent Muscle Wasting. Journal of Cachexia, Sarcopenia and Muscle. 2025;16(6). doi:10.1002/jcsm.70154
BibTeX
@article{Shimada2025,
author = {Shimada, Takashi and Chubachi, Shotaro and Nishikawa, Keisuke and Arai, Tetsuya and Iizuka, Hideto and Otake, Shiro and Sakurai, Kaori and Hamamoto, Junko and Sasaki, Mamoru and Maetani, Tomoki and Tanabe, Naoya and Masaki, Katsunori and Kabata, Hiroki and Miyata, Jun and Yamada, Yoshitake and Jinzaki, Masahiro and Nakamura, Hidetoshi and Asano, Koichiro and Fukunaga, Koichi},
title = {Adipose–Muscle Crosstalk in COPD Cachexia: Early Adipose Atrophy Drives Subsequent Muscle Wasting},
journal = {Journal of Cachexia, Sarcopenia and Muscle},
year = {2025},
volume = {16},
number = {6},
doi = {10.1002/jcsm.70154}
}
EUVIMED